IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2.
作者信息
Lévy Romain, Bastard Paul, Lanternier Fanny, Lecuit Marc, Zhang Shen-Ying, Casanova Jean-Laurent
机构信息
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
University of Paris, Imagine Institute, Paris, France.
出版信息
J Clin Immunol. 2021 Jan;41(1):26-27. doi: 10.1007/s10875-020-00933-0. Epub 2021 Jan 3.
Abstract
摘要
相似文献
1
IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2.干扰素-α2a治疗两名感染新型冠状病毒的Toll样受体3和干扰素调节因子3先天性缺陷患者
J Clin Immunol. 2021 Jan;41(1):26-27. doi: 10.1007/s10875-020-00933-0. Epub 2021 Jan 3.
2
Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity.先天免疫缺陷相关疾病对严重急性呼吸综合征冠状病毒 2 感染宿主防御和疾病发病机制的启示
Curr Opin Allergy Clin Immunol. 2021 Dec 1;21(6):515-524. doi: 10.1097/ACI.0000000000000786.
3
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.COVID-19 危重症患者的 I 型 IFN 免疫先天缺陷。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4570. Epub 2020 Sep 24.
4
Interferon linked to COVID-19 severity.干扰素与新冠病毒疾病严重程度有关。
Nat Med. 2020 Dec;26(12):1806. doi: 10.1038/s41591-020-01164-x.
5
Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review.宿主免疫和炎症反应在伴有基础原发性免疫缺陷的 COVID-19 病例中的作用：综述。
J Interferon Cytokine Res. 2020 Dec;40(12):549-554. doi: 10.1089/jir.2020.0210.
6
Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.不同亚型干扰素-α诱导的免疫特征与抑制 SARS-CoV-2 感染有关。
Proc Natl Acad Sci U S A. 2022 Feb 22;119(8). doi: 10.1073/pnas.2111600119.
7
Effects of Toll-like receptor 3 on herpes simplex virus type-1-infected mouse neural stem cells.Toll样受体3对1型单纯疱疹病毒感染小鼠神经干细胞的影响。
Can J Microbiol. 2015 Mar;61(3):201-8. doi: 10.1139/cjm-2014-0540. Epub 2014 Dec 8.
8
An immunologist's perspective on anti-COVID-19 vaccines.免疫学家对抗 COVID-19 疫苗的看法。
Curr Opin Allergy Clin Immunol. 2021 Dec 1;21(6):545-552. doi: 10.1097/ACI.0000000000000788.
9
Toll like receptor 3 expression as a novel predictor of response to treatment in chronic hepatitis C virus patients.Toll 样受体 3 表达作为慢性丙型肝炎病毒患者治疗反应的新型预测指标。
Scand J Clin Lab Invest. 2011 Dec;71(8):641-6. doi: 10.3109/00365513.2011.624196. Epub 2011 Oct 24.
10
Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study.聚乙二醇干扰素 alfa-2b 在中度 COVID-19 中的疗效和安全性：一项 II 期、随机、对照、开放标签研究。
Int J Infect Dis. 2021 Apr;105:516-521. doi: 10.1016/j.ijid.2021.03.015. Epub 2021 Mar 10.
引用本文的文献
1
Pretreatment with alendronate augments lipid A-induced IFN-β production via upregulation of cGAS expression.阿仑膦酸钠预处理通过上调cGAS表达增强脂多糖诱导的IFN-β产生。
Pharmacol Rep. 2025 Aug 14. doi: 10.1007/s43440-025-00773-y.
2
Role of interferons in the antiviral battle: from virus-host crosstalk to prophylactic and therapeutic potential in SARS-CoV-2 infection.干扰素在抗病毒斗争中的作用：从病毒-宿主相互作用到 SARS-CoV-2 感染的预防和治疗潜力。
Front Immunol. 2024 Jan 15;14:1273604. doi: 10.3389/fimmu.2023.1273604. eCollection 2023.
3
Evaluation of Genetic or Cellular Impairments in Type I IFN Immunity in a Cohort of Young Adults with Critical COVID-19.评价 COVID-19 危重症青年患者 I 型 IFN 免疫中的遗传或细胞损伤。
J Clin Immunol. 2024 Jan 17;44(2):50. doi: 10.1007/s10875-023-01641-1.
4
Human inborn errors of immunity associated with IRF4.与 IRF4 相关的人类先天性免疫缺陷
Front Immunol. 2023 Sep 22;14:1236889. doi: 10.3389/fimmu.2023.1236889. eCollection 2023.
5
TLRs: Innate Immune Sentries against SARS-CoV-2 Infection.TLRs：对抗 SARS-CoV-2 感染的先天免疫哨兵。
Int J Mol Sci. 2023 Apr 29;24(9):8065. doi: 10.3390/ijms24098065.
6
Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria.人类 IRF1 调控巨噬细胞 IFN-γ 对分枝杆菌的免疫反应。
Cell. 2023 Feb 2;186(3):621-645.e33. doi: 10.1016/j.cell.2022.12.038.
7
Innate immune recognition against SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的天然免疫识别
Inflamm Regen. 2023 Jan 26;43(1):7. doi: 10.1186/s41232-023-00259-5.
8
Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity.严重急性呼吸综合征冠状病毒 2 感染和 COVID-19 对先天性免疫缺陷病患者的影响。
J Allergy Clin Immunol. 2023 Apr;151(4):818-831. doi: 10.1016/j.jaci.2022.11.010. Epub 2022 Dec 13.
9
Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19.宿主遗传变异与严重或危重新冠肺炎易感性的临床意义。
Genome Med. 2022 Aug 19;14(1):96. doi: 10.1186/s13073-022-01100-3.
10
COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review.原发性免疫缺陷患者的 COVID-19 相关健康结局：系统评价。
Clin Immunol. 2022 Oct;243:109097. doi: 10.1016/j.clim.2022.109097. Epub 2022 Aug 13.
Zotero 插件